K. Frank

Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.

M. Brandl, G. Fricker, K. Frank, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement.

Gert Fricker, Martin Brandl, Jörg Rosenberg, 2012, International journal of pharmaceutics.

IMI – oral biopharmaceutics tools project – evaluation of bottom‐up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds

Xavier Pepin, Leon Aarons, Hans Lennernäs, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evolution of a mini-scale biphasic dissolution model: Impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics.

C. Kloft, K. Wagner, K. Frank, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of a nanosuspension for iv administration: From miniscale screening to a freeze dried formulation.

G. Boeck, K. Frank, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?

M. Brandl, G. Fricker, K. Frank, 2014, Journal of pharmaceutical sciences.

The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility

Gert Fricker, Martin Brandl, Jörg Rosenberg, 2012, International journal of nanomedicine.

Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".

Gert Fricker, Martin Brandl, M. Brandl, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.

Patrick Augustijns, René Holm, Paul Hutchins, 2017, Molecular pharmaceutics.

In vivo predictive mini-scale dissolution for weak bases: Advantages of pH-shift in combination with an absorptive compartment.

Damir E Zecevic, Karl G Wagner, K. Wagner, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.

J. Dressman, P. Augustijns, R. Holm, 2017, Molecular pharmaceutics.

Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement.

M. Brandl, G. Fricker, K. Frank, 2012, International journal of pharmaceutics.